Skip to main content

CMV Webinar logo and register button

December 14th, 2022
1:00 p.m. CST

This interesting presentation will review The University of Nebraska's Kidney Transplant program's strategy of using CMV inSIGHT T Cell Immunity testing to serially monitor high risk kidney transplant patients to evaluate if prophylaxis could be discontinued early. Dr. Clifford Miles will review data originally presented at the Cutting Edge of Transplantation earlier this year. Dr. Miles is the Medical Director of Kidney and Pancreas Transplant at the University of Nebraska's Medical Center and Associate Professor, Nephrology Division at UNMC's college of medicine. Join us for this special presentation on December 14, 2022. Pre-Register here.

Including a special Q&A between authors of the study.

Servais AM; McMullen JS; Bowen,R; Kleiboeker,S; Miller,M; Duncan,K; Clifford D. Miles. Tailoring CMV prophylaxis based on T cell immunity panel assessment in kidney transplant recipients. American Society of Transplantation: Cutting Edge of Transplantation; Virtual. 2022


CMV cytomegalovirus
Dr. Clifford Miles

Presented By:

Dr. Clifford Miles, MD, FAST
Associate Professor
Internal Medicine-Nephrology
University of Nebraska Medical Center
Medical Director, Kidney & Pancreas Transplantation, Nebraska Medicine

Dr. Miles is a board certified Nephrologist and the Medical Director of the University of Nebraska Medical Center’s Kidney and Pancreas Transplant program. He is originally from Omaha, completing his medical school at the University of Nebraska. He completed his residency at Dartmouth and fellowship at University of Michigan School of Medicine in Ann Arbor. Dr. Miles is interested in the disease process and the delivery of care to the unique patient population of kidney failure and dialysis. He sees his primary responsibility as leading his patients through the true risks and benefits of kidney transplants.

Back to top